Glenmark introduces 3-in-1 inhaler therapy for COPD, promising reduction in risk of severe attacks…
AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population
Backed by latest research which shows significant bronchodilation, with reduction in risk of severe…